Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company dedicated to improving clinical outcomes and enhancing the cost-efficiency of colonoscopy, announced today the first commercial placements of its Pure-Vu® System as part of its initial U.S. market launch targeting...
Intersect ENT, Inc. (NASDAQ: XENT), a company dedicated to transforming care for patients with ear, nose and throat conditions, today announced results from a study of the company’s ASCEND investigational drug-coated sinus balloon....
Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable Sacral Neuromodulation (“SNM”) devices, today announced the presentation of detailed one-year results...
Net sales of $66.0 million, an increase of 3.3% year over year. Gross margin increased 170 basis points year over year to 57.9%. GAAP loss per share of $0.03; adjusted earnings per share of $0.08...
Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced the positive one-year results of its Tack Optimized Balloon Angioplasty (TOBA) III clinical trial, successfully achieving both primary and secondary endpoints. Marianne Brodmann, M.D., Head of the Clinical Division of Angiology...
Ancora Heart, Inc., a company developing a novel therapy to address heart failure, today announced results from an interim analysis of heart failure patients treated in the CorCinch FMR study, a U.S. early feasibility study evaluating the safety of the investigational AccuCinch...
Brainlab, the digital medical technology company, unveiled Loop-X™, the first mobile intraoperative imaging robot today at NASS 2019 in Chicago. Loop-X sits at the core of the Brainlab Digital Surgery portfolio...
Abiomed’s (NASDAQ: ABMD) newest heart pump, the Impella 5.5 with SmartAssist, has received U.S. Food and Drug Administration (FDA) pre-market approval (PMA) for safety and efficacy in the therapy of cardiogenic shock for up to 14 days....
Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced the initial surgeries of the PROLIFT Lateral Expandable Spacer System....
Biomechanically, the Luna device performed better in reducing intervertebral motion than the Anterior Lumbar Interbody Fusion (ALIF) control cage ...